Christophe Lurquin

Person

Brussels, BE

People

Patents Grantslast 30 patents

Information Patent Grant
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3
- Patent number 7,923,534
- Issue date Apr 12, 2011
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens and CTL clones isolated by a novel procedure
- Patent number 7,351,409
- Issue date Apr 1, 2008
- Ludwig Institute for Cancer Research
- Pascal Chaux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen...
- Patent number RE40089
- Issue date Feb 19, 2008
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- 536 - Organic compounds
Information Patent Grant
Tumor antigens and CTL clones isolated by a novel procedure
- Patent number 6,710,172
- Issue date Mar 23, 2004
- Ludwig Institute for Cancer Research
- Pascal Chaux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor antigens and CTL clones isolated by a novel procedure
- Patent number 6,531,451
- Issue date Mar 11, 2003
- Ludwig Institute for Cancer Research
- Pascal Chaux
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating cancer by administering MAGE-derived peptides
- Patent number 6,488,932
- Issue date Dec 3, 2002
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens and CTL clones isolated by a novel procedure
- Patent number 6,407,063
- Issue date Jun 18, 2002
- Ludwig Institute for Cancer Research
- Rosalie Luiten
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated protein molecules which are members of the MAGE-B family
- Patent number 6,392,016
- Issue date May 21, 2002
- Ludwig Institute for Cancer Research
- Christophe Lurquin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated nonapeptides which bind to HLA molecules and provoke lysis...
- Patent number 6,034,214
- Issue date Mar 7, 2000
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecules which are members of the MAGE-B fam...
- Patent number 6,017,705
- Issue date Jan 25, 2000
- Ludwig Institute for Cancer Research
- Christophe Lurquin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor rejection antigen precursors, tumor rejection antigens and us...
- Patent number 5,925,729
- Issue date Jul 20, 1999
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for determining lung adenocarcinomas by assaying for one or...
- Patent number 5,763,155
- Issue date Jun 9, 1998
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for determining lung adenocarcinomas by assaying for one or...
- Patent number 5,763,165
- Issue date Jun 9, 1998
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of screening for cancer by detecting messenger RNA for a MAG...
- Patent number 5,759,783
- Issue date Jun 2, 1998
- Ludwig Institute for Cancer Research
- Christophe Lurquin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated nucleic acid molecules which are members of the MAGE-Xp fa...
- Patent number 5,587,289
- Issue date Dec 24, 1996
- Ludwig Institute for Cancer Research
- Christophe Lurquin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated nucleic acid molecules which encode MAGE derived nonapeptides
- Patent number 5,462,871
- Issue date Oct 31, 1995
- Ludwig Institute for Cancer Research
- Thierry Boon-Falleur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nonapeptides derived from MAGE genes and uses thereof
- Patent number 5,405,940
- Issue date Apr 11, 1995
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleotide sequence encoding the tumor rejection antigen precursor,...
- Patent number 5,342,774
- Issue date Aug 30, 1994
- Ludwig Institute for Cancer Research
- Thierry Boon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Tumor antigens and CTL clones isolated by a novel procedure
- Publication number 20040185033
- Publication date Sep 23, 2004
- Pascal Chaux
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT ADENOVIRAL VECTORS FOR HUMAN TUMOUR GENE THERAPY
- Publication number 20030082150
- Publication date May 1, 2003
- THIERRY BOON-FALLEUR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christophe Lurquin

Person

Patents Grantslast 30 patents

Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3

Tumor antigens and CTL clones isolated by a novel procedure

Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen...

Tumor antigens and CTL clones isolated by a novel procedure

Tumor antigens and CTL clones isolated by a novel procedure

Method for treating cancer by administering MAGE-derived peptides

Tumor antigens and CTL clones isolated by a novel procedure

Isolated protein molecules which are members of the MAGE-B family

Isolated nonapeptides which bind to HLA molecules and provoke lysis...

Isolated nucleic acid molecules which are members of the MAGE-B fam...

Tumor rejection antigen precursors, tumor rejection antigens and us...

Method for determining lung adenocarcinomas by assaying for one or...

Method for determining lung adenocarcinomas by assaying for one or...

Method of screening for cancer by detecting messenger RNA for a MAG...

Isolated nucleic acid molecules which are members of the MAGE-Xp fa...

Isolated nucleic acid molecules which encode MAGE derived nonapeptides

Isolated nonapeptides derived from MAGE genes and uses thereof

Nucleotide sequence encoding the tumor rejection antigen precursor,...

Patents Applicationslast 30 patents

Tumor antigens and CTL clones isolated by a novel procedure

RECOMBINANT ADENOVIRAL VECTORS FOR HUMAN TUMOUR GENE THERAPY